BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26321746)

  • 21. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
    Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
    Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.
    Garzon R; Liu S; Fabbri M; Liu Z; Heaphy CE; Callegari E; Schwind S; Pang J; Yu J; Muthusamy N; Havelange V; Volinia S; Blum W; Rush LJ; Perrotti D; Andreeff M; Bloomfield CD; Byrd JC; Chan K; Wu LC; Croce CM; Marcucci G
    Blood; 2009 Jun; 113(25):6411-8. PubMed ID: 19211935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fusaric acid-induced promoter methylation of DNA methyltransferases triggers DNA hypomethylation in human hepatocellular carcinoma (HepG2) cells.
    Ghazi T; Nagiah S; Naidoo P; Chuturgoon AA
    Epigenetics; 2019 Aug; 14(8):804-817. PubMed ID: 31060424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
    Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
    Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory Traits of Dendrosome Curcumin (DNC) on Breast Cancer Compared to Curcumin Single Compound.
    Alghanimi YK; Ghasemian A
    J Gastrointest Cancer; 2020 Jun; 51(2):527-533. PubMed ID: 31286422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic Activation of Cytochrome P450 1A2 Sensitizes Hepatocellular Carcinoma Cells to Sorafenib.
    Zhang Y; Feng J; Mi Y; Fan W; Qin R; Mei Y; Jin G; Mao J; Zhang H
    Drug Metab Dispos; 2024 May; 52(6):555-564. PubMed ID: 38565301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372.
    Wang Y; Hu Y; Wu G; Yang Y; Tang Y; Zhang W; Wang K; Liu Y; Wang X; Li T
    Oncotarget; 2017 May; 8(21):34429-34441. PubMed ID: 28415780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated analysis of gene expression and DNA methylation changes induced by hepatocyte growth factor in human hepatocytes.
    Xie CR; Sun H; Wang FQ; Li Z; Yin YR; Fang QL; Sun Y; Zhao WX; Zhang S; Zhao WX; Wang XM; Yin ZY
    Mol Med Rep; 2015 Sep; 12(3):4250-4258. PubMed ID: 26099202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A.
    Wei X; Xiang T; Ren G; Tan C; Liu R; Xu X; Wu Z
    Cell Signal; 2013 Feb; 25(2):439-46. PubMed ID: 23124077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The long noncoding RNA
    Ren Y; Shang J; Li J; Liu W; Zhang Z; Yuan J; Yang M
    J Biol Chem; 2017 Oct; 292(43):17939-17949. PubMed ID: 28887306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of
    Wu G; Ju X; Wang Y; Li Z; Gan X
    Cell Cycle; 2019 Aug; 18(16):1849-1867. PubMed ID: 31258024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA Fer-1-like protein 4 acts as a tumor suppressor via miR-106a-5p and predicts good prognosis in hepatocellular carcinoma.
    Wu J; Huang J; Wang W; Xu J; Yin M; Cheng N; Yin J
    Cancer Biomark; 2017 Jul; 20(1):55-65. PubMed ID: 28759956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
    Fan JC; Zeng F; Le YG; Xin L
    J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma.
    Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J
    Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
    Fabbri M; Garzon R; Cimmino A; Liu Z; Zanesi N; Callegari E; Liu S; Alder H; Costinean S; Fernandez-Cymering C; Volinia S; Guler G; Morrison CD; Chan KK; Marcucci G; Calin GA; Huebner K; Croce CM
    Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15805-10. PubMed ID: 17890317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer.
    Zhang J; Liu J; Xu X; Li L
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):479-487. PubMed ID: 28175963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.